
NextPlat Corp. (NASDAQ:NXPL – Free Report) – Equities researchers at Litchfield Hills Research lifted their Q1 2027 earnings per share (EPS) estimates for shares of NextPlat in a report issued on Monday, August 17th. Litchfield Hills Research analyst T. O’neill now expects that the company will earn $0.11 per share for the quarter, up from their prior forecast of $0.10. Litchfield Hills Research currently has a “Buy” rating and a $11.00 price objective on the stock. The consensus estimate for NextPlat’s current full-year earnings is ($0.55) per share. Litchfield Hills Research also issued estimates for NextPlat’s Q2 2027 earnings at $0.16 EPS and FY2027 earnings at $0.61 EPS.
NextPlat (NASDAQ:NXPL – Get Free Report) last announced its quarterly earnings data on Thursday, August 13th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.21) by $0.16. The firm had revenue of $11.88 million for the quarter, compared to analysts’ expectations of $11.00 million. NextPlat had a negative return on equity of 53.16% and a negative net margin of 20.38%.
View Our Latest Stock Report on NextPlat
NextPlat Stock Performance
Shares of NASDAQ NXPL opened at $8.07 on Wednesday. The stock has a market capitalization of $21.85 million, a P/E ratio of -2.20 and a beta of 1.83. The firm’s 50-day moving average price is $6.50 and its two-hundred day moving average price is $5.98. NextPlat has a 52-week low of $3.38 and a 52-week high of $11.10. The company has a quick ratio of 2.12, a current ratio of 2.56 and a debt-to-equity ratio of 0.05.
Hedge Funds Weigh In On NextPlat
An institutional investor recently bought a new stake in NextPlat stock. Citadel Advisors LLC bought a new stake in shares of NextPlat Corp. (NASDAQ:NXPL – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned approximately 0.19% of NextPlat as of its most recent SEC filing. Hedge funds and other institutional investors own 1.30% of the company’s stock.
NextPlat Company Profile
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.
Further Reading
- Five stocks we like better than NextPlat
- Amazon Plugs $18B Into the Southern Power Grid
- Speed Sells: Cerebras Cracks the Silicon Ceiling
- Amid Legal Risks, This Company Is Still Rated a Buy
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.
